Alagille Syndrome
- PMID: 29939604
- Bookshelf ID: NBK507827
Alagille Syndrome
Excerpt
Alagille syndrome (ALGS) is a multisystem autosomal dominant disorder with a wide variety of clinical manifestations. It is also known as arteriohepatic dysplasia, Alagille-Watson syndrome, Watson-Miller syndrome, or syndromic bile duct paucity. The clinical manifestations are variable, even within the same family, and commonly include hepatic (cholestasis, characterized by bile duct paucity on liver biopsy), cardiac (primarily involving the pulmonary arteries), renal skeletal (butterfly vertebrae), ophthalmologic (posterior embryotoxon), and facial abnormalities. Alagille syndrome can range from a subclinical presentation to a life-threatening condition, with a mortality rate up to 10%.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Benabed Y, Chaillou E, Denis MC, Simard G, Reynier P, Homedan C. Alagille syndrome: a case report. Ann Biol Clin (Paris) 2018 Dec 01;76(6):675-680. - PubMed
-
- Mitchell E, Gilbert M, Loomes KM. Alagille Syndrome. Clin Liver Dis. 2018 Nov;22(4):625-641. - PubMed
-
- Junge N, Dingemann J, Petersen C, Manns MP, Richter N, Klempnauer J, Baumann U, Schneider A. [Biliary atresia and congenital cholestatic syndromes : Characteristics before, after and during transition]. Internist (Berl) 2018 Nov;59(11):1146-1156. - PubMed
Publication types
LinkOut - more resources
Full Text Sources